Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

12.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.5K
Positive Regulator Molecules02:39

Positive Regulator Molecules

7.0K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
7.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incidence of Surgical-Site Infections Following Oral and Maxillofacial Surgery: A Systematic Review and Meta-Analysis.

Journal of maxillofacial and oral surgery·2026
Same author

Integrating SICLOPPS screening with next-generation sequencing for the discovery of cyclic peptide modulators of protein-protein interactions.

Methods in enzymology·2025
Same author

Author Correction: Characterisation of a cyclic peptide that binds to the RAS binding domain of phosphoinositide 3-kinase p110α.

Scientific reports·2025
Same author

Hypoxia-inducible transcription factors: architects of tumorigenesis and targets for anticancer drug discovery.

Transcription·2024
Same author

Next Generation SICLOPPS Screening for the Identification of Inhibitors of the HIF-1α/HIF-1β Protein-Protein Interaction.

ACS chemical biology·2024
Same author

Identification and Development of Cyclic Peptide Inhibitors of Hypoxia Inducible Factors 1 and 2 That Disrupt Hypoxia-Response Signaling in Cancer Cells.

Journal of the American Chemical Society·2024

Related Experiment Video

Updated: Mar 6, 2026

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
08:48

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 26, 2016

12.5K

SICLOPPS cyclic peptide libraries in drug discovery.

Ali Tavassoli1

  • 1Chemistry, University of Southampton, Southampton SO17 1BJ, United Kingdom.

Current Opinion in Chemical Biology
|March 5, 2017
PubMed
Summary

Genetically encoded cyclic peptide libraries offer advantages for drug discovery. The split-intein circular ligation of peptides and proteins (SICLOPPS) method enables efficient identification of peptide inhibitors for challenging targets.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Drug Discovery

Background:

  • Cyclic peptides show promise for targeting difficult biological interactions, including protein-protein interactions.
  • Genetically encoded peptide libraries are advantageous over chemical synthesis due to accessibility and ease of hit identification.
  • Split-intein circular ligation of peptides and proteins (SICLOPPS) is a key method for intracellular library generation.

Purpose of the Study:

  • To detail and discuss the application of SICLOPPS for generating cyclic peptide libraries.
  • To highlight the utility of SICLOPPS in identifying inhibitors for various biological targets.

Main Methods:

  • Utilizing the SICLOPPS technique for the intracellular generation of cyclic peptide libraries.
  • Employing these libraries to screen for and identify peptide inhibitors.

More Related Videos

Constructing Cyclic Peptides Using an On-Tether Sulfonium Center
07:11

Constructing Cyclic Peptides Using an On-Tether Sulfonium Center

Published on: September 28, 2022

3.2K
Construction of Cyclic Cell-Penetrating Peptides for Enhanced Penetration of Biological Barriers
10:12

Construction of Cyclic Cell-Penetrating Peptides for Enhanced Penetration of Biological Barriers

Published on: September 19, 2022

2.9K

Related Experiment Videos

Last Updated: Mar 6, 2026

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
08:48

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 26, 2016

12.5K
Constructing Cyclic Peptides Using an On-Tether Sulfonium Center
07:11

Constructing Cyclic Peptides Using an On-Tether Sulfonium Center

Published on: September 28, 2022

3.2K
Construction of Cyclic Cell-Penetrating Peptides for Enhanced Penetration of Biological Barriers
10:12

Construction of Cyclic Cell-Penetrating Peptides for Enhanced Penetration of Biological Barriers

Published on: September 19, 2022

2.9K

Main Results:

  • Demonstrated the successful deployment of SICLOPPS for library creation.
  • Showcased the identification of cyclic peptide inhibitors against diverse targets using this approach.

Conclusions:

  • SICLOPPS is a powerful and versatile method for generating genetically encoded cyclic peptide libraries.
  • This approach facilitates the discovery of novel cyclic peptide inhibitors for challenging therapeutic targets.